A detailed history of Kynam Capital Management, LP transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 5,953,825 shares of TSVT stock, worth $17.8 Million. This represents 2.31% of its overall portfolio holdings.

Number of Shares
5,953,825
Previous 5,953,825 -0.0%
Holding current value
$17.8 Million
Previous $22.9 Million 22.6%
% of portfolio
2.31%
Previous 1.78%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$3.14 - $11.2 $3.34 Million - $11.9 Million
1,063,119 Added 21.74%
5,953,825 $23.3 Million
Q2 2023

Aug 14, 2023

BUY
$8.45 - $12.48 $9.73 Million - $14.4 Million
1,151,734 Added 30.8%
4,890,706 $49.5 Million
Q1 2023

May 15, 2023

BUY
$9.21 - $14.98 $34.4 Million - $56 Million
3,738,972 New
3,738,972 $38.1 Million

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Kynam Capital Management, LP Portfolio

Follow Kynam Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.